Humacyte is a biotechnology company in North Carolina that develops biological treatments for blood vessel and vascular diseases. Its filings show it lobbies Congress and federal agencies about Medicare and Medicaid reimbursement for biologic products and about access to and procurement of biologic treatments for military service members and warfighters. It has spent about $100,000 across three filings and used Capitol Hill Consulting Group.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRIAN SUTTER
The latest disclosures for this client.
CAPITOL HILL CONSULTING GROUP
Q1CAPITOL HILL CONSULTING GROUP
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CAPITOL HILL CONSULTING GROUP
EMILY ELIZABETH WILKINSON-HOLLAND
CAPITOL HILL CONSULTING GROUP
KIMBERLEE TRZECIAK
CAPITOL HILL CONSULTING GROUP
mr CHRISTOPHER DAVIS
CAPITOL HILL CONSULTING GROUP
CAPITOL HILL CONSULTING GROUP
Q3CAPITOL HILL CONSULTING GROUP
RR